檢索結果 - AM Almeida
- Showing 1 - 6 results of 6
-
1
-
2
-
3
DARATUMUMAB (DARA), CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE FOR TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TE NDMM) PATIENTS: RESPONSE RATE IMPACTS ON PFS 由 EQ Crusoé, JSLRD Santos, JAD Santos, HHM Santos, AS Santos, LF Lucas, AM Almeida, VT Hungria, MA Salvino, MGB Arruda
出版 2022Artigo -
4
沒有標題 由 LC Albuquerque, AM Almeida, AGV Bitencourt, RM Vieira de Mello, AM Farias, AS Souza Filho, OH Messeder, JM Teles, Maíra Pereira Dantas
出版 2005Artigo -
5
-
6
相關主題
Medicine
Family medicine
Internal medicine
Biology
Chemotherapy
Cochrane Library
Context (archaeology)
Creatinine
Curriculum
Cyclophosphamide
Daratumumab
Dexamethasone
Emergency medicine
Engineering
Fibrinolytic agent
Gastroenterology
Gynecology
Intensive care medicine
Lenalidomide
Mechanical engineering
Medical education
Meta-analysis
Multiple myeloma
Myocardial infarction
Oncology
Paleontology
Pedagogy
Psychology
Streptokinase
Stroke (engine)